Filters

reset all
See more specimen types...

Other countries

Results: 1 to 4 of 4

Tests names and labsConditionsGenes and analytesMethods

RET, selective sequencing of exons 5, 8, 10, 11 and 13-16

Centogene AG - the Rare Disease Company
Germany
61
  • T Targeted variant analysis

RET. Detection of the mutations p.Met918Thr and p.Ala883Phe by sequencing

Instituto de Medicina Genomica
Spain
11
  • T Targeted variant analysis

Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
10999
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Multiple Endocrine Neoplasia Type 2B (MEN2B) via the RET Gene, Exons 15-16

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Results: 1 to 4 of 4

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center